This Action aims at using innovative translational research to identify colorectal cancer biomarkers for personalized medicine that will improve screening, early detection and disease follow-up, and attain better tumor profiling, state-of-the-art functional characterization of genetic variants and new therapy approaches
This congress is organized by some participants of our COST Action (María José Serrano, Juan José Díaz, Carmen Garrido, José Antonio Lorente) and we are disseminating it to other participants in case they may be interested.
This meeting will focus on Tumor profiling (WG3). It will include a Management Committee meeting. Therefore, official MC members will be compulsory invited following COST regulations.
Friday, 16 October 2020
Dr Barbara Pardini, participant of the COST Action TRANSCOLONCAN from the Italian Institute for Genomic Medicine, has been appointed guest editor of the special issue of Non-Coding RNA entitled "Non-coding RNAs as Colorectal Cancer Biomarkers: Mechanisms of Action and Treatment Options".